secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2026-06-08T20:05:15+00:00
Accession:  0001193125-26-261693
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics 2026 annual meeting results: all director nominees and proposals approved
--------------------------------------------------------------------------------

- John Evans, John Maraganore, and Christi Shaw elected as Class III directors with 71.7M, 64.8M, and 65.7M votes for respectively.
- Ratification of Deloitte as auditor for FY2026 passed with 85.8M votes for, 165.7K against.
- Advisory say-on-pay resolution approved with 71.5M for, 985.1K against.
- Broker non-votes totaled approximately 13.4M shares for director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526261693/0001193125-26-261693-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526261693/beam-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-261693

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer